Marketing-authorisation holder · Spain
Laboratoire X.O
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| NIMOTOP 0,2 mg/ml SOLUCION PARA PERFUSION10 mg · Solución para perfusión | Nimodipine | Spain | Marketed | 1988 |
| VASONASE 1 mg/ml SOLUCIÓN PARA PERFUSIÓN5 mg · Solución para perfusión | Nicardipine | Spain | Marketed | 1998 |
| VASONASE 20 mg COMPRIMIDOS RECUBIERTOS20 mg · Comprimido recubierto | Nicardipine | Spain | Marketed | 1983 |
| VASONASE 30 mg CÁPSULAS DURAS30 mg · Cápsula dura | Nicardipine | Spain | Marketed | 1990 |
| NIMOTOP 30 mg, COMPRIMIDOS RECUBIERTOS CON PELICULA30 mg · Comprimido recubierto con película | Nimodipine | Spain | Suspended | 1988 |
| VASONASE RETARD 40 mg CÁPSULAS DURAS DE LIBERACIÓN MODIFICADA40 mg · Cápsula dura de liberación prolongada | Nicardipine | Spain | Withdrawn | 1996 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines |
|---|